Anxiety Disorders Recruiting Phase 2 Trials for Lysergic acid diethylamide (DB04829)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03153579LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety DisordersTreatment